CHLORPHENIRAMINE MALEATE
-
chlorpheniramine maleate tablet
Cardinal Health
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
----------
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers
When using this product
If pregnant or breast-feeding, ask a health professional before use.
adults and children 12 years of age and over | 1 tablet every 4 to 6 hours. Do not take more than 6 tablets in 24 hours. |
children 6 to under 12 years of age | 1/2 tablet (break tablet in half) every 4 to 6 hours. Do not exceed 3 whole tablets in 24 hours. |
children under 6 years of age | do not use this product in children under 6 years of age. |
Anhydrous lactose, corn starch, D&C yellow #10 aluminum lake, magnesium stearate, microcrystalline cellulose
TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
Store at 20 to 25 C (68 to 77 F). [See USP Controlled Room Temperature.]
Questions or comments?
1-800-848-0462
Serious side effects associated with use of this product may be reported to this number.
Chlorpheniramine Maleate Tablets are available as follows:
4 mg - Round, convex, yellow tablets bisected and imprinted with 44 over 194 on one side.
NDC 51079-163-20 - Unit dose blister packages of 100 (10 cards of 10 tablets each).
Manufactured by:
LNK International, Inc.
Hauppauge, NY 11788
Distributed by:
UDL Laboratories, Inc.
Rockford, IL 61103
S-5563 R9
6/10
CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
Unapproved drug other | 06/06/2011 |
Labeler - Cardinal Health (188557102) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Cardinal Health | 188557102 | REPACK |
Revised: 07/2011 Cardinal Health